Why the study?
MINOCA occurs in 6% to 15% of myocardial infarctions and diagnosis is challenging, requiring intracoronary imaging, physiology testing, and CMR.
What is the role of intracoronary imaging (IVUS and OCT) and CMR in diagnosing the underlying mechanisms of MINOCA to guide targeted therapy?
What is the role of intracoronary imaging (IVUS and OCT) and CMR in diagnosing the underlying mechanisms of MINOCA to guide targeted therapy?
Intracoronary imaging (IVUS and OCT) combined with CMR is essential for identifying the specific pathophysiologic mechanisms of MINOCA to enable targeted therapeutic strategies.
Answers are grounded in this paper and cite their sources.
May support targeted MINOCA therapy via imaging plus CMR; extends observational data but leaves open need for RCTs.
Myocardial infarction with non-obstructive coronary artery disease occurs in 6% to 15% of all presentation of myocardial infarctions. The pathophysiologic mechanisms of MINOCA include epicardial vasospasm, coronary microvascular disorder, spontaneous coronary artery dissection, and coronary thrombus/embolism. The diagnosis is challenging, supported by intracoronary imaging with intravascular ultrasound (IVUS) and optical coherent tomography (OCT), coronary physiology testing, and cardiac magnetic resonance imaging (CMR). OCT is able to identify atherosclerotic causes of MINOCA (plaque erosion, plaque rupture, and calcified nodule) and nonatherosclerotic causes (spontaneous artery dissection, and spasm). In this review, we summarize the performance of the two intracoronary imaging modalities (IVUS and OCT) in MINOCA and discuss the importance of supplementing these modalities with CMR in order to drive target therapy.
No takes yet. Share an insight, caveat, or question.
Borzillo et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: